Central regions | Technology & innovation

Moscow State University develops new thyroid gland cancer drug

16 Oct '13
A research team at Lomonosov Moscow State University (MSU) is developing an innovation y-tracer called “Astat-211” to fight thyroid gland cancer, announced MSU’s Skobeltsyn Institute of Nuclear Physics, the prime driver of the new project.

The research effort is being pushed by a scientific team led by Prof. O. A. Yuminov.

The new y-tracer is based on the 211-At radioactive nuclide, believed to be a powerful anti-tumor weapon, and is expected to be more efficient in cancer therapies while substantially decreasing radiation doses for patients and medical staff, compared to the conventional y-tracers currently using the 131-I nuclide. Unlike the future y-tracer, the 131-I is a source of β- and γ-rays that possess a considerable penetrating power—up to a few centimeters in biological tissues. This results in exposing patients to a relatively large dose of healthy organ irradiation, while the destruction of cancerous cells is far from efficient.

The 211-At radioactive nuclide emits high-energy α-particles that only penetrate about 50-70 microns of biological tissues, just a few diameters of a cell. So, if the drug is delivered close to an organ bearing a malignant tumor, it’s cancerous cells that will predominantly be destroyed.

In preliminary experiments the Skobeltsyn Institute team found out that being a chemical analog of the 131-I, the 211-At is capable of selectively accumulating in the thyroid gland and participating in this organ’s metabolic processes.

The 211-At’s above properties are expected to pave the way for its broad use in thyroid gland cancer therapies.

The 211-At is an artificial isotope unavailable in nature. At the moment, the MSU Skobeltsyn Institute researchers are conducting preclinical trials of the new Astat-211 y-tracer.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Moscow

Tags: cancer (63) / MSU (40) / y tracer (1) / thyroid gland (1) / Astat 211 (0) /

Latest News: Central regions
22 Jun '18 | Technology & innovation | Finance, business
21 Jun '18 | Technology & innovation
20 Jun '18 | Finance, business | Technology & innovation
18 Jun '18 | Finance, business | Technology & innovation
 

Feature stories

7 Jun '18
Russian scientists have come up with a new method of...
3 Apr '18
In regions most of European Russians will hardly ever...
21 Nov '17
Russian scientists have come up with what they say is...
Search (News archive - 21248)
Advertising
RB_Partners_Report
Advertising
gcvsymposium
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

22 Jun '18
Russia ranked 40th among 63 countries in the...
21 Jun '18
Russian scientists have developed new biosensor chips...
20 Jun '18
TeleMD, a Russian start-up, is developing a software...

Most read stories from last week